Sebastián Cippitelli
CEO / Co-Founder
B
B4Tomorrow
Shutdownb4tomorrow-bio.com
Website unreachable since Oct 26, 2026
This startup is developing an AI bioplatform focused on cellular rejuvenation and neurodegenerative disease treatments. Their platform aims to provide personalized gene-specific therapies, enabling preventive diagnosis and continuous monitoring for conditions like Alzheimer's and Parkinson's.
- Artificial Intelligence
- Biotechnology
- Digital Health
Updated 6 months ago
Funding
Funding rounds are not available yet.
Founders
Product
Features
- This startup is developing an AI bioplatform focused on cellular rejuvenation and neurodegenerative disease treatments. Their platform aims to provide personalized gene-specific therapies, enabling preventive diagnosis and continuous monitoring for conditions like Alzheimer's and Parkinson's.